Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 401.85
+7.85 (1.99%)
Oct 7, 2026, 3:14 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 9.51 billion as of October 7, 2026. That makes Bafna Pharmaceuticals the world's 25,587th most valuable company and 1,661st in India. Its market cap has increased by 132.77% in one year.
Market Cap
9.51B
Enterprise Value
9.86B
Revenue
1.43B
Global Rank
Country Rank
#1,661 India
PE Ratio
123.87
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 9.51B, an increase of 87,258.68%. That is a compound annual growth rate of 178.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 9.51B | 166.62% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 34.49B |
| Ind-Swift Laboratories | 34.36B |
| Sakar Healthcare | 23.92B |
| Indoco Remedies | 23.24B |
| Windlas Biotech | 22.34B |
| Beta Drugs | 21.02B |
| Anlon Healthcare | 17.47B |
| Jagsonpal Pharmaceuticals | 15.28B |